May 2nd 2024
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
New Cholesterol Treatment Guideline: A Q&A With Thomas Dayspring, MD, FACP, FNLA, NCMP
March 5th 2014Thomas Dayspring, MD, FACP, FNLA, NCMP, discusses the promises and pitfalls of the 2013 American College of Cardiology/American Heart Association Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
Study Finds Substantial Variation in Antiplatelet Use Based on Patient Characteristics
November 19th 2013Although oral antiplatelet therapy is broadly supported as preventive therapy for patients with established atherosclerotic vascular disease, researchers say emerging evidence for specific agents shows heterogeneous outcomes by symptomatic vascular bed, and patterns of use may vary by symptomatic territory.
Nonalcoholic Fatty Liver Disease Boosts Cardiovascular Risk, But Lacks Management Plan
May 21st 2013Growing evidence suggests increased cardiovascular risk in patients with nonalcoholic fatty liver disease (NAFLD) - in particular nonalcoholic steatohepatitis (NASN) - but no data exists to support a specific management approach.
New Diabetes Management Guidelines Consider Concurrent Conditions
In diagnosing a patient with type 2 diabetes, an endocrinologist or primary care physician may struggle with developing healthy treatment targets when comorbid conditions like obesity and hypoglycemia are at play.
Omega-3 Therapy Vascepa Reduces Triglycerides in Severe Hypertriglyceridemia Patients
As an adjunct to diet and exercise, Amarin's lipid-regulating agent Vascepa (icosapent ethyl capsules) is indicated to reduce triglyceride levels in adult patients with severe hypertriglyceridemia, or very high triglyceride (TG) levels greater than or equal to 500 milligrams per deciliter (mg/dL).
Top 5 Mobile Apps for Rheumatologists
From full-motion video demonstrations of orthopedic clinical tests to suites of disease activity score calculators, these apps for Google and Apple mobile devices provide rheumatologists with useful and easy-to-access information at crucial moments in diagnosis and treatment.
Modern Technology Reveals Atherosclerosis Was Prevalent in Ancient Populations
March 11th 2013Investigators in the expanded HORUS trial using CT scans of ancient mummies from multiple populations and geographic regions report finding evidence of probable or definite atherosclerosis in nearly one-third of samples.
FREEDOM Study Reveals CABG is More Cost-Effective than PCI for Patients with Diabetes
November 6th 2012Study results presented at AHA 2012 indicate that revascularization using CABG in diabetic patients with multivessel disease provides better clinical outcomes than PCI and is more cost effective in the long run.
Chelation Therapy Does not Improve Quality of Life in Treated Heart Attack Patients
November 6th 2012Results from a sub-study of the Trial to Assess Chelation Therapy (TACT) that focused on quality of life issues in patients who had previously suffered a heart attack and were treated with chelation therapy reveal no improvements in these patients' quality of life.
Restrictions on Sugar Consumption Recommended
February 2nd 2012Consumption of sugar, which helps to drive the obesity crisis and causes millions of deaths worldwide each year, should be controlled like other threats to public health, a team of researchers from the University of California San Francisco argue in the Feb. 2 issue of Nature.